GoodRx Holdings, Inc. (GDRX) Operating Income (Loss) USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GoodRx Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • GoodRx Holdings, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was $7.38 M, a 34.7% decline year-over-year.
  • GoodRx Holdings, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$30.9 M, a 360% decline year-over-year.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2023 was -$27 M, a 1654% decline from 2022.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2022 was $1.74 M, a 87% decline from 2021.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2021 was $13.4 M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$27 M -$28.7 M -1654% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $1.74 M -$11.7 M -87% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $13.4 M +$289 M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$276 M -$415 M -297% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $140 M +$62.4 M +80.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $77.3 M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.